Understanding how young adults use nicotine and cannabis together
Official title: Predictors and Consequences of Nicotine and Cannabis Vaping Co-use in Young Adults: A Longitudinal and EMA Analysis
Funded at Rand Corporation · NIH-11057727 · Data updated 2026-11-12
This study is looking at how young adults who use both nicotine and cannabis through vaping are affected by it in their daily lives, aiming to understand how these substances work together and impact their health and happiness.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | April 1, 2021 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $383,908 |
| NIH project number | 5R37CA249707-05 |
| Project ID | NIH-11057727 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are young adults aged 18-24 who use both nicotine and cannabis products.
✕Less likely to help
Patients who do not use nicotine or cannabis products may not benefit from this research.
What this research studies
This research investigates the patterns and effects of young adults co-using nicotine and cannabis through vaping. By utilizing Ecological Momentary Assessment (EMA), the study captures real-time data on daily usage and its consequences. It also analyzes long-term survey data to identify predictors of co-use and its impact on mental and physical health. The goal is to better understand how these substances interact and affect young people's well-being.
Why it matters
Potential benefit: If successful, this research could lead to improved public health strategies aimed at reducing the risks associated with vaping nicotine and cannabis among young adults.
How similar studies have gone: While there has been research on combustible tobacco and cannabis use, this study's focus on vaping co-use is relatively novel and untested.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Dunbar, Michael — Rand Corporation
- Study coordinator: Dunbar, Michael
Related research
Other NIH-funded projects on the same topics.
-
Helping Parents Prevent Adolescent Vaping: A Longitudinal Study and Experimental Messages
A study with 12-year-olds’ families aims to understand how parental knowledge and parenting practices influence teens’ nicotine and cannabis vaping, and tests messages to help parents prevent vaping.
-
Chemicals released by vaping cannabis
This work looks at which chemicals are produced when people vape concentrated cannabis and how different devices and formulations change those emissions, with special attention to risks for young users.
-
Investigating the chemicals and toxic emissions from cannabis vaping
This study is looking at how vaping cannabis affects health, especially for young people, by figuring out what harmful chemicals are released when different types of cannabis and vaporizers are used, so we can better understand the safety of these products.
-
How local tobacco and cannabis stores affect teen vaping habits
This study looks at how having more tobacco and cannabis shops close to homes and schools affects young people's vaping habits, especially if they live in less advantaged neighborhoods, to help create better policies to reduce vaping among teens.
-
Investigating the effects of vaping nicotine and cannabis in young people
This study is looking at how vaping nicotine and cannabis impacts young people aged 12 to 20, to see if it leads to more smoking or if it’s linked to other challenges they might be facing, with the goal of helping to create better health strategies for them.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.